Roivant Sciences

Ultime notizie

Titoli nella lingua originale della fonte.

• Here’s How Much You Would Have Made Owning Roivant Sciences Stock In The Last 5 Years (si apre in una nuova scheda)

  Benzinga · 1 ott 2026

• Why Did DELL, ROIV, SHEL Stocks Surge To 52-Week Highs Today? (si apre in una nuova scheda)

  Stocktwits · 1 ott 2026

• Form 144 Roivant Sciences Ltd. For: 1 October By Investing.com (si apre in una nuova scheda)

  Investing.com Canada · 1 ott 2026

• Roivant Sciences Ltd. (ROIV) Stock Forecasts (si apre in una nuova scheda)

  Yahoo! Finance Canada · 1 ott 2026

• After a $7.15M August sale, Roivant (ROIV) officer Eric Venker proposes another share sale. (si apre in una nuova scheda)

  Stock Titan · 30 set 2026

• Roivant Sciences Ltd. (ROIV) Stock Price, News, Quote & History (si apre in una nuova scheda)

  Yahoo! Finance Canada · 30 set 2026

• Roivant Sciences gains as investors appear to keep rewarding recent clinical and regulatory momentum (si apre in una nuova scheda)

  Quiver Quantitative · 28 set 2026

• Roivant Sciences Targets LISRAYA Launch, Key Pipeline Readouts in Next 12 Months (si apre in una nuova scheda)

  es.tradingview.com · 28 set 2026

• Form 4 Roivant Sciences Ltd. For: 28 September By Investing.com (si apre in una nuova scheda)

  Investing.com Nigeria · 28 set 2026

• Cantor Fitzgerald reiterates Roivant Sciences stock rating (si apre in una nuova scheda)

  Investing.com · 24 set 2026

• Roivant Sciences (ROIV) Reiterated at Overweight by Cantor Fitzgerald (si apre in una nuova scheda)

  StreetInsider · 24 set 2026

• Roivant slips on trial setback for Immunovant (ROIV:NASDAQ) (si apre in una nuova scheda)

  Seeking Alpha · 23 set 2026

• Roivant halts IMVT-1402 development in cutaneous lupus after trial miss (si apre in una nuova scheda)

  StreetInsider · 23 set 2026

• Behavioral Patterns of ROIV and Institutional Flows (si apre in una nuova scheda)

  Stock Traders Daily · 23 set 2026

• Roivant (ROIV) CAO uses 3,880 shares to cover RSU taxes (si apre in una nuova scheda)

  Stock Titan · 23 set 2026

• Roivant Plunges After Founder’s Billion-Dollar Stock Sale (si apre in una nuova scheda)

  TipRanks · 22 set 2026

• Roivant (ROIV): $9 Billion Sales Potential Faces a Commercialization Test (si apre in una nuova scheda)

  Yahoo Finance · 22 set 2026

• Roivant Sciences (ROIV) CFO now holds 269,681 shares after RSU tax withholding (si apre in una nuova scheda)

  Stock Titan · 22 set 2026

• New stock awards for Roivant Sciences (ROIV) director vest in 2027 (si apre in una nuova scheda)

  Stock Titan · 18 set 2026

• What Is Roivant Sciences (ROIV) Signaling With Its Positive PH ILD Trial Data? (si apre in una nuova scheda)

  Yahoo Finance · 18 set 2026

• Roivant Sciences (ROIV) gives director new options and RSUs (si apre in una nuova scheda)

  Stock Titan · 18 set 2026

• Roivant Sciences (ROIV) grants director stock awards vesting in 2027 (si apre in una nuova scheda)

  Stock Titan · 18 set 2026

• Roivant Sciences (ROIV) director now holds 8.97M shares (si apre in una nuova scheda)

  Stock Titan · 18 set 2026

• Roivant Sciences (ROIV) director receives new 2027-vesting equity grant (si apre in una nuova scheda)

  Stock Titan · 18 set 2026

• Director at Roivant (ROIV) receives new stock awards (si apre in una nuova scheda)

  Stock Titan · 18 set 2026

• JPMorgan reiterates Roivant Sciences stock rating on survey data By Investing.com (si apre in una nuova scheda)

  Investing.com India · 17 set 2026

• Roivant Sciences (ROIV) director sells 5,112 shares under pre-set plan (si apre in una nuova scheda)

  Stock Titan · 17 set 2026

• Roivant Sciences (ROIV) Reiterated at Overweight by JPMorgan on Lisraya Feedback (si apre in una nuova scheda)

  StreetInsider · 17 set 2026

• Roivant Sciences (NASDAQ: ROIV) director sells 4,938 shares under 10b5-1 plan (si apre in una nuova scheda)

  Stock Titan · 17 set 2026

• Stifel initiates Roivant Sciences stock with buy rating, $51 target (si apre in una nuova scheda)

  Investing.com · 16 set 2026